Sign in

NCT06768996Active, not recruiting

Music, Social Attention, and Dementia

The Impact of a Caregiver-patient Music Intervention on Social Attention and Connectedness in Persons Living With bvFTD and AD

Source: ClinicalTrials.gov · Last updated 3 Dec 2025

Brief summary (registry, in English)

This is an exploratory mixed-methods control-treatment study to evaluate if participation in rhythmic musical activities improves social attention and connectedness in individuals living with mild to moderate bvFTD and AD, and their caregivers. Secondary objectives include evaluating the potential relationships between brain networks associated with rhythm production, social attention, and connectedness in these populations.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
80 (actual)
First submitted
5 Dec 2024
Start date
10 Jan 2025
Primary completion date
31 Aug 2026
Lead sponsor
University of California, San Francisco
NCT number
NCT06768996

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 10 Jan 2025 to the primary completion date, 31 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inclusion (patients)
  • Male or female ≥ 55 years of age living with bvFTD; or ≥ 70 years of age living with AD.
  • Documentation of a bvFTD or AD diagnosis as evidenced by one or more known clinical features.
  • Written informed consent obtained from subject.
    • Inclusion (caregivers)
  • Male or female ≥ 55 years of age living without diagnosis of neurological or psychiatric disease.
  • Individual capable of independent execution of activities of daily living, including personal care and hygiene, dressing, eating, use of a toilet, and mobility.
  • Written informed consent.
    • Exclusion (patients)
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  • community-dwelling individuals not living with bvFTD
    • community-dwelling individuals with normal cognitive functioning
    • Individuals living with Alzheimer's disease or related dementias (primary progressive aphasia, semantic variant FTD, Lewy body dementia, vascular dementia, Parkinson's disease, or mixed dementia)
  • Individuals with a score of 2 or higher on the CDR
  • Individuals with a history of neuropsychiatric illness that would interfere with performance (e.g., transient psych hx of depression okay, hx of schizophrenia will be excluded) or medicated depression to control symptoms.
  • Individuals with unstable (e.g., cancer other than basal cell skin) or chronic (e.g., severe diabetes) medical conditions
  • Individuals with MRI contraindications (e.g., pregnancy, claustrophobia, metal implants that are contraindicated for MRI)
  • Individuals with physical impairment(s) precluding motor response
  • Individuals with inability to walk two blocks without stopping
  • Individuals with hearing or vision deficits that will not allow for completion of testing; inability to hear conversation conducted at an average volume (\~60 dB)
  • Individuals who practice music making or production for at least 30-mins per week
    • This may include instrumental or vocal, writing or arranging, alone or in groups
    • Listening to music for more than 30-mins weekly will not exclude the individual from the study
    • Exclusion (Caregivers)
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  • Community-dwelling individuals living with diagnosis of a neurological or psychiatric disease
    • o Community-dwelling individuals with abnormal cognitive functioning
  • Individuals living with dementia
  • Individuals with a history of neuropsychiatric illness that would interfere with performance (e.g., transient psych hx of depression okay, hx of schizophrenia will be excluded) or medicated depression to control symptoms
  • Individuals with unstable (e.g., cancer other than basal cell carcinoma) or chronic (e.g., severe diabetes) medical conditions
  • Individuals with physical impairment(s) precluding motor control
  • Individuals with inability to walk two blocks without stopping
  • Individuals with hearing or vision deficits that will not allow for completion of testing; inability to hear conversation conducted at an average volume (\~60 dB)
  • Individuals who practice music making or production for at least 30-mins per week
    • This may include instrumental or vocal, writing or arranging, alone or in groups
    • Listening to music for more than 30-mins weekly will not exclude the individual from the study

Age in the registry: 55 years to 89 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Sandler Neurosciences Center
Coordinator of this site? Confirm its status
San FranciscoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.